TP53 and breast carcinoma: However, a significant portion of TNBC, especially those cancers not related to BRCA1, do not harbor p53 mutations [5], suggesting other molecular etiological factors may simultaneously abrogate HR and p53 functions to contribute to the subset of breast cancers that are unrelated to BRCA1 and p53.